Vallejo, Carlos http://orcid.org/0000-0002-8484-8097
Rosell, Ana
Xicoy, Blanca
García, Carmen
Albo, Carmen
Polo, Marta
Jarque, Isidro
Esteban, Brígida
Codesido, M. Lorena
Funding for this research was provided by:
Novartis S.A.
Article History
Received: 22 June 2023
Accepted: 21 December 2023
First Online: 4 January 2024
Declarations
:
: The present study was approved by the institutional review board at the coordinating center, the Hospital Universitario Donostia, San Sebastián, Spain (Basque Country Ethics Committee Ref.: EPA2017043-SP) and it was carried out in accordance with the Helsinki declaration regarding research on humans.
: All patients provided their written informed consent to participate in the study.
: CV received research funding from Novartis S.A. However, the funding body did not influence the performance of the study in any way, nor the preparation of the manuscript or the decision to publish. AR, BX, CG, CA, MP, IJ, BE, and MLC have no competing interests to declare that are relevant to the content of this article.